2340-PUB: Success of Online CME at Improving the Clinical Knowledge and Confidence in Using SGLT1/SGLT2 Inhibitors in T1D Management

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2340-PUB
Author(s):  
AMY LARKIN ◽  
MICHAEL LACOUTURE ◽  
ANNE LE
Keyword(s):  
Sglt2 Inhibitors ◽  
Clinical Knowledge

Developing Evidence-Based Assessment to Prevent Over- or Underidentification of Disorders for New Language Learners

2020 ◽  
Vol 5 (4) ◽  
pp. 1026-1038
Author(s):  
Sandra Levey ◽  
Li-Rong Lilly Cheng ◽  
Diana Almodovar
Keyword(s):  
Language Learners ◽  
Grade Level ◽  
Reading Skills ◽  
Language Disorder ◽  
Academic Development ◽  
Review Article ◽  
Evidence Based ◽  
Clinical Knowledge ◽  
Language And Literacy ◽  
Support Evidence

Purpose The purpose of this review article is to present certain linguistic domains to consider in the assessment of children learning a new language. Speech-language pathologists frequently face difficulty when determining if a bilingual or multilingual child possesses a true speech or language disorder. Given the increased number of new language learners across the world, clinicians must understand differences versus disorders to prevent underidentification or overidentification of a disorder. Conclusions Early identification of a true disorder has been shown to prevent language and literacy difficulties, given that children are able to achieve grade-level reading skills when given intervention. Clinical knowledge and skills are strongly required so that children receive evidence-based assessment to support their academic development. Learning Goal Readers will gain an understanding of the factors that support evidence-based assessment of bilingual and multilingual language learners.

Abstract #208: SGLT2 Inhibitors in Ketoacidosis: The Culprit or an Innocent Bystander?

2016 ◽  
Vol 22 ◽  
pp. 33
Author(s):  
Gaurav Bhalla ◽  
Naveen Kakumanu ◽  
Preethi Krishnan ◽  
Saleh Aldasouqi
Keyword(s):  
Sglt2 Inhibitors ◽  
Innocent Bystander

An Electronic Study Form to Support Collaborating Agents in the Management of Clinical Knowledge

1999 ◽  
Vol 38 (03) ◽  
pp. 154-157
Author(s):  
W. Fierz ◽  
R. Grütter
Keyword(s):  
Procedural Knowledge ◽  
Health Care Provision ◽  
Markup Language ◽  
Artificial Agents ◽  
Care Provision ◽  
Clinical Knowledge ◽  
Extensible Markup ◽  
Implementation Level ◽  
Biological Organisms ◽  
Representation Of Knowledge

AbstractWhen dealing with biological organisms, one has to take into account some peculiarities which significantly affect the representation of knowledge about them. These are complemented by the limitations in the representation of propositional knowledge, i. e. the majority of clinical knowledge, by artificial agents. Thus, the opportunities to automate the management of clinical knowledge are widely restricted to closed contexts and to procedural knowledge. Therefore, in dynamic and complex real-world settings such as health care provision to HIV-infected patients human and artificial agents must collaborate in order to optimize the time/quality antinomy of services provided. If applied to the implementation level, the overall requirement ensues that the language used to model clinical contexts should be both human- and machine-interpretable. The eXtensible Markup Language (XML), which is used to develop an electronic study form, is evaluated against this requirement, and its contribution to collaboration of human and artificial agents in the management of clinical knowledge is analyzed.

SGLT2 Inhibitors Suppress Alpha-Adrenergic Tone and Morning Elevation of Plasma Glucose Levels

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1667-P
Author(s):  
KEISHI YAMAUCHI
Keyword(s):  
Plasma Glucose ◽  
Sglt2 Inhibitors ◽  
Glucose Levels

Comparative Cardiovascular Efficacy of SGLT2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Agonists—A Network Meta-analysis

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 427-P
Author(s):  
ALISTAIR J. RODDICK ◽  
SEAN ZHENG
Keyword(s):  
Meta Analysis ◽  
Sglt2 Inhibitors

2354-PUB: Estimating Improvement of TGF Mechanism from Changes of Urinary Glucose and Sodium Excretion by SGLT2 Inhibitors

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2354-PUB
Author(s):  
CHIZURU WATANABE ◽  
YASUMICHI MORI
Keyword(s):  
Sodium Excretion ◽  
Sglt2 Inhibitors ◽  
Urinary Glucose

2350-PUB: Renoprotective Effects of SGLT2 Inhibitors in Japanese Real-World Clinical Practice

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2350-PUB
Author(s):  
TAKAHIRO TOSAKI ◽  
SHIORI TOGA SATO ◽  
MASAKI KONDO ◽  
YUICHIRO YAMADA ◽  
AKEMI INAGAKI ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Real World ◽  
Sglt2 Inhibitors

1110-P: Effect of Raised Alanine Transaminase (ALT) Levels on HbA1c in the Association of British Clinical Diabetologists (ABCD) Nationwide Audits of SGLT2 Inhibitors (SGLT2i)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1110-P
Author(s):  
HARSHAL DESHMUKH ◽  
ALEX BICKERTON ◽  
SUZANNE M. PHILLIPS ◽  
ALISON EVANS ◽  
RAJEEV P. RAGHAVAN ◽  
...  
Keyword(s):  
Alanine Transaminase ◽  
Sglt2 Inhibitors
Sign in / Sign up

Export Citation Format

Share Document